Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Greenwich LifeSciences, Inc. (GLSI)
USD19.44
+0.43 (+2.24%)
US NASDAQ Healthcare Biotechnology
Address
Building 14 77477
Stafford, TX, US
Stafford, TX, US
CEO
Snehal S. Patel
Website
greenwichlifesciences.com
IPO
2020-09-25
CIK 1799788 ISIN US3968791083
Description
Greenwich LifeSciences, Inc. functions as a clinical-stage biopharmaceutical company, dedicated to developing innovative cancer immunotherapies. These treatments are primarily focused on breast cancer and other HER2/neu-positive malignancies. Its flagship therapeutic candidate is GP2, an immunotherapy which has successfully completed its Phase IIb clinical trials. This drug is designed to prevent the recurrence of breast cancer in patients who have already undergone surgical removal of the tumor. Founded in 2006 and based in Stafford, Texas, the company was formerly known as Norwell, Inc. until it rebranded to Greenwich LifeSciences, Inc. in March 2018.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD19.44
+0.43 (+2.24%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
142.8K
Beta
1.38
Float Shares
6.57M
Free Float %
47.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.55% | -19.33% | +7.69% | -12.33% | +168.98% | +12.66% | +153.43% | +115.57% | -39.40% | +373.40% | +373.40% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (2 ratings, all time)
Buy
Price Targets & DCF
Current price
19.44
Low
50.00
+157.3%
Consensus
50.00
+157.3%
Median
50.00
+157.3%
High
50.00
+157.3%
DCF (Unlevered)
0.23
-98.8%
DCF (Levered)
0.31
-98.4%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 1 |
50.00
+157.3%
|
| All Time | 1 |
50.00
+157.3%
|
Quality scores
Altman Z-Score
22.22
Safe zone
Piotroski F-Score
2 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
2 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%-18.2% Q1'26: -56.0% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%-228.0% Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+4.0% Q1'26: +10.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×0.00× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
—
|
—
|
—
— – —
|
8.75M
8.75M – 8.75M
|
140.00M
140.00M – 140.00M
+1,500.0% YoY
|
310.63M
310.63M – 310.63M
+121.9% YoY
|
| EBITDA |
-15.79M
|
-19.45M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-15.79M
|
-19.45M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-15.79M
est: -10.41M (-51.6%)
|
-19.36M
est: -16.51M (-17.2%)
|
-18.27M
-20.03M – -16.51M
-10.7% YoY
|
-19.90M
-19.90M – -19.90M
-8.9% YoY
|
53.87M
53.87M – 53.87M
+370.7% YoY
|
134.00M
134.00M – 134.00M
+148.7% YoY
|
| SGA |
3.06M
|
2.23M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-1.21
est: -0.80 (-51.3%)
|
-1.43
est: -1.23 (-16.7%)
|
-1.35
-1.48 – -1.22
-10.2% YoY
|
-1.47
-1.47 – -1.47
-8.9% YoY
|
3.98
3.98 – 3.98
+370.7% YoY
|
9.90
9.90 – 9.90
+148.7% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
Owner's Earnings history not available.
Owner alignment
Owner's Earnings TTM
—
OE per share TTM
—
Owner's Yield
—
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
—
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
63
Total invested
41.13M
Insider transactions (90d)
0
Beneficial owners (>5%)
16
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Snehal Patel | 7.78M | 64.98% | 1.18M | 6.59M | 1.18M | 6.59M | IN | USA | 2020-10-13 | ↗ |
| 2 | Patel Family Trust 1 | 2.41M | 20.10% | — | 2.41M | — | 2.41M | OO | Texas | 2020-10-13 | ↗ |
| 3 | Weiner | 2.30M | 17.70% | — | 2.30M | — | 2.30M | IN | TX | 2022-06-22 | ↗ |
| 4 | Snehal Patel IRA | 1.41M | 11.76% | — | 1.41M | — | 1.41M | OO | Utah | 2020-10-13 | ↗ |
| 5 | Patel Family Trust 3 | 1.33M | 11.11% | — | 1.33M | — | 1.33M | OO | Texas | 2020-10-13 | ↗ |
| 6 | Patel Family Trust 2 | 1.32M | 11.03% | — | 1.32M | — | 1.32M | OO | Texas | 2020-10-13 | ↗ |
| 7 | David McWilliams | 604.5K | 5.03% | 604.5K | — | 604.5K | — | IN | USA | 2020-11-30 | ↗ |
| 8 | Trust 2 | 424.8K | 3.30% | 424.8K | — | 424.8K | — | OO | TX | 2022-06-22 | ↗ |
| 9 | Trust 1 | 421.8K | 3.20% | 421.8K | — | 421.8K | — | OO | TX | 2022-06-22 | ↗ |
| 10 | Kinnary Patel IRA | 129.4K | 1.08% | — | 129.4K | — | 129.4K | OO | Utah | 2020-10-13 | ↗ |
| 11 | MA Trust 1 | 105.7K | 0.80% | 105.7K | — | 105.7K | — | OO | TX | 2022-06-22 | ↗ |
| 12 | MA Trust 2 | 105.6K | 0.80% | 105.6K | — | 105.6K | — | OO | TX | 2022-06-22 | ↗ |
| 13 | MI Trust 3 | 105.6K | 0.80% | 105.6K | — | 105.6K | — | OO | TX | 2022-06-22 | ↗ |
| 14 | MA Trust 3 | 94.8K | 0.70% | 94.8K | — | 94.8K | — | OO | TX | 2022-06-22 | ↗ |
| 15 | MI Trust 1 | 94.8K | 0.70% | 94.8K | — | 94.8K | — | OO | TX | 2022-06-22 | ↗ |
| 16 | MI Trust 2 | 94.8K | 0.70% | 94.8K | — | 94.8K | — | OO | TX | 2022-06-22 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
63
+14 vs prev Q
New positions
25
Closed positions
11
Increased
42
Reduced
11
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | BLACKROCK, INC. | 371.5K +8.2K (+2.2%) | 7.80M +4.2M (+115.9%) | 2.72% +0.006 pp | 0.00% +0.000 pp | USD14.24 +47.5% | 6 qtrs — |
| 2 | VANGUARD GROUP INC | 296.6K +14.4K (+5.1%) | 6.23M +3.4M (+122.0%) | 2.17% +0.064 pp | 0.00% +0.000 pp | USD23.27 -9.7% | 21 qtrs — |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 151.7K +9.6K (+6.7%) | 3.19M +1.8M (+125.4%) | 1.11% +0.049 pp | 0.00% +0.000 pp | USD21.88 -4.0% | 21 qtrs — |
| 4 | STATE STREET CORP | 97.8K +15.8K (+19.3%) | 2.05M +1.2M (+151.9%) | 0.72% +0.104 pp | 0.00% +0.000 pp | USD19.91 +5.5% | 19 qtrs — |
| 5 | CREDIT AGRICOLE S A | 87.0K +87.0K (+100.0%) | 1.83M +1.8M (+100.0%) | 0.64% +0.638 pp | 0.00% +0.004 pp | USD21.01 +0.0% | 1 qtrs NEW |
| 6 | NORTHERN TRUST CORP | 73.0K -2.9K (-3.8%) | 1.53M +778.7K (+103.1%) | 0.54% -0.033 pp | 0.00% +0.000 pp | USD13.08 +60.6% | 9 qtrs — |
| 7 | VIRTU FINANCIAL LLC | 28.8K +28.8K (+100.0%) | 605.0K +605.0K (+100.0%) | 0.21% +0.211 pp | 0.02% +0.023 pp | USD21.01 +0.0% | 1 qtrs NEW |
| 8 | MAN GROUP PLC | 28.1K +28.1K (+100.0%) | 589.7K +589.7K (+100.0%) | 0.21% +0.206 pp | 0.00% +0.001 pp | USD21.01 +0.0% | 1 qtrs NEW |
| 9 | MORGAN STANLEY | 26.4K +17.7K (+202.5%) | 554.2K +467.4K (+538.7%) | 0.19% +0.128 pp | 0.00% +0.000 pp | USD18.95 +10.9% | 21 qtrs — |
| 10 | GOLDMAN SACHS GROUP INC | 21.5K +1.7K (+8.6%) | 452.7K +255.2K (+129.2%) | 0.16% +0.010 pp | 0.00% +0.000 pp | USD10.15 +107.0% | 5 qtrs — |
| 11 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 19.0K +39.0 (+0.2%) | 400.1K +211.0K (+111.6%) | 0.14% -0.003 pp | 0.00% +0.000 pp | USD15.79 +33.1% | 7 qtrs — |
| 12 | BANK OF NEW YORK MELLON CORP | 13.9K -1.3K (-8.3%) | 291.3K +140.8K (+93.5%) | 0.10% -0.012 pp | 0.00% +0.000 pp | USD14.80 +42.0% | 7 qtrs — |
| 13 | CITADEL ADVISORS LLC | 11.8K -9.1K (-43.5%) | 248.5K +40.2K (+19.3%) | 0.09% -0.070 pp | 0.00% +0.000 pp | USD9.67 +117.3% | 4 qtrs — |
| 14 | XTX TOPCO LTD | 10.3K +10.3K (+100.0%) | 216.9K +216.9K (+100.0%) | 0.08% +0.076 pp | 0.01% +0.006 pp | USD21.01 +0.0% | 1 qtrs NEW |
| 15 | BARCLAYS PLC | 9.7K +1.2K (+13.8%) | 204.7K +81.7K (+66.4%) | 0.07% +0.007 pp | 0.00% +0.000 pp | USD13.52 +55.4% | 7 qtrs — |
| 16 | JANE STREET GROUP, LLC | 9.7K +9.7K (+100.0%) | 203.3K +203.3K (+100.0%) | 0.07% +0.071 pp | 0.00% +0.000 pp | USD21.01 +0.0% | 1 qtrs NEW |
| 17 | RHUMBLINE ADVISERS | 8.1K -1.1K (-11.8%) | 169.9K +78.7K (+86.3%) | 0.06% -0.009 pp | 0.00% +0.000 pp | USD14.19 +48.1% | 7 qtrs — |
| 18 | WELLS FARGO & COMPANY/MN | 7.8K +4.1K (+109.6%) | 164.8K +127.6K (+342.6%) | 0.06% +0.030 pp | 0.00% +0.000 pp | USD17.44 +20.5% | 13 qtrs — |
| 19 | BANK OF AMERICA CORP /DE/ | 7.2K +2.3K (+47.4%) | 151.0K +102.5K (+211.2%) | 0.05% +0.016 pp | 0.00% +0.000 pp | USD16.51 +27.3% | 21 qtrs — |
| 20 | UBS GROUP AG | 6.1K +2.0K (+48.1%) | 127.7K +86.9K (+212.7%) | 0.04% +0.014 pp | 0.00% +0.000 pp | USD14.42 +45.7% | 22 qtrs — |
| 21 | DEUTSCHE BANK AG\ | 6.1K -15.5K (-71.9%) | 127.1K -86.8K (-40.6%) | 0.04% -0.117 pp | 0.00% +0.000 pp | USD9.95 +111.2% | 2 qtrs — |
| 22 | NEW YORK STATE COMMON RETIREMENT FUND | 6.0K +— (+0.0%) | 126.1K +66.4K (+111.2%) | 0.04% -0.001 pp | 0.00% +0.000 pp | USD16.77 +25.3% | 7 qtrs — |
| 23 | STRS OHIO | 5.7K -14.3K (-71.5%) | 119.8K -79.2K (-39.8%) | 0.04% -0.108 pp | 0.00% 0.000 pp | USD13.66 +53.8% | 7 qtrs — |
| 24 | FMR LLC | 4.0K +1.1K (+39.7%) | 84.1K +55.6K (+195.0%) | 0.03% +0.008 pp | 0.00% +0.000 pp | USD12.71 +65.3% | 16 qtrs — |
| 25 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 3.1K +88.0 (+3.0%) | 64.4K +34.8K (+117.4%) | 0.02% +0.000 pp | 0.00% +0.000 pp | USD14.23 +47.6% | 6 qtrs — |
| 26 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 2.8K +— (+0.0%) | 58.2K +30.6K (+111.2%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD9.07 +131.6% | 3 qtrs — |
| 27 | JPMORGAN CHASE & CO | 2.7K +136.0 (+5.4%) | 56.2K +31.0K (+122.5%) | 0.02% +0.001 pp | 0.00% +0.000 pp | USD11.55 +81.9% | 11 qtrs — |
| 28 | NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 2.1K +— (+0.0%) | 44.1K +23.2K (+111.2%) | 0.02% 0.000 pp | 0.01% +0.004 pp | USD10.41 +101.8% | 18 qtrs — |
| 29 | BNP PARIBAS ARBITRAGE, SNC | 1.8K +702.0 (+61.7%) | 38.7K +27.3K (+241.4%) | 0.01% +0.005 pp | 0.00% +0.000 pp | USD14.36 +46.3% | 5 qtrs — |
| 30 | TOWER RESEARCH CAPITAL LLC (TRC) | 1.2K -121.0 (-9.5%) | 24.3K +11.6K (+91.2%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD10.32 +103.6% | 20 qtrs — |
| 31 | ROYAL BANK OF CANADA | 998.00 -233.0 (-18.9%) | 20.0K +8.0K (+66.7%) | 0.01% -0.002 pp | 0.00% +0.000 pp | USD10.89 +92.9% | 7 qtrs — |
| 32 | FARTHER FINANCE ADVISORS, LLC | 919.00 +919.0 (+100.0%) | 19.3K +19.3K (+100.0%) | 0.01% +0.007 pp | 0.00% +0.000 pp | USD21.01 +0.0% | 1 qtrs NEW |
| 33 | AMERITAS INVESTMENT PARTNERS, INC. | 585.00 +— (+0.0%) | 12.3K +6.5K (+111.1%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD16.77 +25.3% | 7 qtrs — |
| 34 | LEGAL & GENERAL GROUP PLC | 581.00 -81.0 (-12.2%) | 12.2K +5.6K (+85.3%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD16.77 +25.3% | 7 qtrs — |
| 35 | RUSSELL INVESTMENTS GROUP, LTD. | 560.00 -89.0 (-13.7%) | 11.8K +5.3K (+82.2%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD9.54 +120.2% | 4 qtrs — |
| 36 | FOUNDERS CAPITAL MANAGEMENT | 500.00 +— (+0.0%) | 10.5K +5.5K (+111.2%) | 0.00% 0.000 pp | 0.01% +0.003 pp | USD8.47 +148.1% | 15 qtrs — |
| 37 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 385.00 -49.0 (-11.3%) | 8.1K +3.8K (+87.3%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD16.75 +25.4% | 7 qtrs — |
| 38 | CITIGROUP INC | 227.00 -38.0 (-14.3%) | 4.8K +2.1K (+80.8%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD12.97 +62.0% | 9 qtrs — |
| 39 | WASHINGTON TRUST ADVISORS, INC. | 200.00 +— (+0.0%) | 4.2K +2.2K (+111.2%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD10.52 +99.7% | 9 qtrs — |
| 40 | UBS ASSET MANAGEMENT AMERICAS INC | 193.00 +193.0 (+100.0%) | 4.1K +4.1K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD21.01 +0.0% | 1 qtrs NEW |
| 41 | AMALGAMATED BANK | 197.00 -10.0 (-4.8%) | 4.0K +2.0K (+100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD16.77 +25.3% | 7 qtrs — |
| 42 | OPTIVER HOLDING B.V. | 96.00 +— (+0.0%) | 2.0K +1.1K (+111.2%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD9.95 +111.2% | 2 qtrs — |
| 43 | GENEOS WEALTH MANAGEMENT INC. | 88.00 +— (+0.0%) | 1.8K +973.0 (+111.1%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD9.65 +117.7% | 11 qtrs — |
| 44 | NORTH STAR INVESTMENT MANAGEMENT CORP. | 51.00 +— (+0.0%) | 1.1K +565.0 (+111.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD15.20 +38.2% | 13 qtrs — |
| 45 | STERLING CAPITAL MANAGEMENT LLC | 40.00 +25.0 (+166.7%) | 840.00 +691.0 (+463.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD17.30 +21.4% | 6 qtrs — |
| 46 | PNC FINANCIAL SERVICES GROUP, INC. | 17.00 -12.0 (-41.4%) | 357.00 +68.0 (+23.5%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD9.88 +112.7% | 2 qtrs — |
| 47 | ADVISOR GROUP HOLDINGS, INC. | 6.00 +— (+0.0%) | 126.00 +65.0 (+106.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD9.00 +133.4% | 3 qtrs — |
| 48 | EVERSOURCE WEALTH ADVISORS, LLC | 5.00 -27.0 (-84.4%) | 105.00 -213.0 (-67.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD9.00 +133.4% | 4 qtrs — |
| 49 | SUNBELT SECURITIES, INC. | 2.00 -3.0 (-60.0%) | 42.00 -8.0 (-16.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD9.50 +121.2% | 2 qtrs — |
| 50 | RENAISSANCE TECHNOLOGIES LLC | — -38.4K (-100.0%) | — -382.1K (-100.0%) | 0.00% -0.287 pp | 0.00% -0.001 pp | USD— | 17 qtrs SOLD |
| 51 | MILLENNIUM MANAGEMENT LLC | — -15.5K (-100.0%) | — -154.2K (-100.0%) | 0.00% -0.116 pp | 0.00% 0.000 pp | USD— | 3 qtrs SOLD |
| 52 | SBI SECURITIES CO., LTD. | — -30.0 (-100.0%) | — -299.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 5 qtrs SOLD |
| 53 | SRS CAPITAL ADVISORS, INC. | — -123.0 (-100.0%) | — -1.2K (-100.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 54 | CWM, LLC | — -60.0 (-100.0%) | — -1.0K (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 55 | NISA INVESTMENT ADVISORS, LLC | — -27.0 (-100.0%) | — -269.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
| 56 | GLOBAL RETIREMENT PARTNERS, LLC | — -45.0 (-100.0%) | — -448.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 57 | HOPWOOD FINANCIAL SERVICES, INC. | — -50.0 (-100.0%) | — -498.0 (-100.0%) | 0.00% 0.000 pp | 0.00% 0.000 pp | USD— | 5 qtrs SOLD |
| 58 | MARSHALL WACE, LLP | — -32.1K (-100.0%) | — -318.9K (-100.0%) | 0.00% -0.240 pp | 0.00% 0.000 pp | USD— | 3 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 43 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Franklin Small Cap Enhanced ETF FSML | 0.07% | 105.4K | 0.45% |
| 2 | Vanguard Global Momentum Factor ETF VMO.TO | 0.06% | 225.4K | 0.38% |
| 3 | Vanguard U.S. Momentum Factor ETF VFMO | 0.04% | 637.5K | 0.13% |
| 4 | iShares Micro-Cap ETF IWC | 0.03% | 449.2K | 0.60% |
| 5 | Innovator U.S. Small Cap Managed Floor ETF RFLR | 0.02% | 20.7K | 0.89% |
| 6 | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF GSSC | 0.02% | 174.2K | 0.20% |
| 7 | Vanguard Russell 2000 Growth ETF VTWG | 0.01% | 156.5K | 0.06% |
| 8 | iShares Russell 2000 Growth ETF IWO | 0.01% | 1.26M | 0.24% |
| 9 | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) R2US.L | 0.01% | 352.2K | 0.30% |
| 10 | Invesco Russell 2000 Dynamic Multifactor ETF OMFS | 0.01% | 15.1K | 0.39% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
2
Sells
0
Shares acquired
4.7K
Shares disposed
—
Cash buys
2.00
Cash sales
—
Net activity
+4,700
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-13 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,800 | 29.83 | 53.7K | 5,604,102 | D | ↗ |
| 2026-01-12 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,900 | 27.54 | 79.9K | 5,602,302 | D | ↗ |
| 2025-12-31 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 4,300 | 21.36 | 91.8K | 5,599,402 | D | ↗ |
| 2025-12-30 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,900 | 21.73 | 63.0K | 5,595,102 | D | ↗ |
| 2025-12-18 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 4,100 | 12.62 | 51.7K | 5,592,202 | D | ↗ |
| 2025-11-25 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 4,600 | 8.37 | 38.5K | 5,588,102 | D | ↗ |
| 2025-11-13 | Patel Snehal | Director / Officer / 10% Owner | A-Award | A | Stock Options | 100,000 | 8.20 | 820.0K | 2,347,462 | D | ↗ |
| 2025-11-07 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 10,600 | 8.43 | 89.4K | 5,583,502 | D | ↗ |
| 2025-10-31 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,300 | 9.26 | 21.3K | 5,572,902 | D | ↗ |
| 2025-04-25 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 3,600 | 9.88 | 35.6K | 5,570,602 | D | ↗ |
| 2025-04-17 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 5,400 | 8.98 | 48.5K | 5,567,002 | D | ↗ |
| 2025-04-07 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 3,600 | 9.10 | 32.8K | 5,561,602 | D | ↗ |
| 2025-04-04 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 5,500 | 8.73 | 48.0K | 5,558,002 | D | ↗ |
| 2025-01-10 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,500 | 12.51 | 31.3K | 5,552,502 | D | ↗ |
| 2025-01-07 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,800 | 13.75 | 24.8K | 5,550,002 | D | ↗ |
| 2025-01-06 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,100 | 13.31 | 14.6K | 5,548,202 | D | ↗ |
| 2025-01-03 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 3,400 | 12.95 | 44.0K | 5,547,102 | D | ↗ |
| 2025-01-02 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,000 | 11.97 | 23.9K | 5,543,702 | D | ↗ |
| 2024-12-31 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,400 | 11.36 | 27.3K | 5,541,702 | D | ↗ |
| 2024-12-30 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 3,200 | 11.12 | 35.6K | 5,539,302 | D | ↗ |
| 2024-12-24 | Thompson Jaye | Officer | A-Award | A | Stock Options | 149,818 | 12.16 | 1.82M | 299,636 | D | ↗ |
| 2024-12-24 | Rothe Eric | Director | A-Award | A | Stock Options | 41,349 | 12.16 | 502.8K | 82,698 | D | ↗ |
| 2024-12-24 | Patel Snehal | Director / Officer / 10% Owner | A-Award | A | Stock Options | 1,148,723 | 12.16 | 13.97M | 2,222,454 | D | ↗ |
| 2024-12-24 | McWilliams David | Director | A-Award | A | Stock Options | 61,984 | 12.16 | 753.7K | 123,968 | D | ↗ |
| 2024-12-24 | Hallock Kenneth | Director | A-Award | A | Stock Options | 41,349 | 12.16 | 502.8K | 82,698 | D | ↗ |
| 2024-12-24 | Daugherty Frank Joseph | Director / Officer | A-Award | A | Stock Options | 104,890 | 12.16 | 1.28M | 209,780 | D | ↗ |
| 2024-11-21 | Thompson Jaye | Officer | P-Purchase | A | Common Stock | 1,000 | 12.91 | 12.9K | 264,148 | D | ↗ |
| 2024-09-26 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,500 | 14.63 | 21.9K | 5,536,102 | D | ↗ |
| 2024-08-12 | Thompson Jaye | Officer | P-Purchase | A | Common Stock | 800 | 13.85 | 11.1K | 263,148 | — | ↗ |
| 2024-08-06 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,000 | 13.81 | 27.6K | 5,534,602 | — | ↗ |
| 2024-08-05 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 5,500 | 13.18 | 72.5K | 5,532,602 | — | ↗ |
| 2024-08-02 | Thompson Jaye | Officer | P-Purchase | A | Common Stock | 1,000 | 15.15 | 15.2K | 262,348 | — | ↗ |
| 2024-07-23 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,500 | 15.89 | 23.8K | 5,527,102 | — | ↗ |
| 2024-07-18 | Thompson Jaye | Officer | P-Purchase | A | Common Stock | 1,000 | 16.00 | 16.0K | 261,348 | — | ↗ |
| 2024-06-13 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 174,825 | 14.30 | 2.50M | 5,525,602 | — | ↗ |
| 2024-04-01 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 3,000 | 19.08 | 57.2K | 5,350,777 | — | ↗ |
| 2024-03-22 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,500 | 19.98 | 50.0K | 5,347,777 | — | ↗ |
| 2024-03-20 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,500 | 17.68 | 26.5K | 5,345,277 | — | ↗ |
| 2024-03-05 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 30,500 | 12.49 | 380.9K | 5,343,777 | — | ↗ |
| 2024-03-04 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 4,100 | 13.03 | 53.4K | 5,340,277 | — | ↗ |
| 2024-02-16 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 10,800 | 11.16 | 120.5K | 5,336,177 | — | ↗ |
| 2024-02-15 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 12,700 | 11.07 | 140.6K | 5,325,377 | — | ↗ |
| 2023-11-10 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 5,000 | 10.17 | 50.8K | 5,312,677 | — | ↗ |
| 2023-11-03 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 3,500 | 9.11 | 31.9K | 5,307,677 | — | ↗ |
| 2023-10-27 | Thompson Jaye | Officer | P-Purchase | A | Common Stock | 500 | 8.57 | 4.3K | 260,348 | — | ↗ |
| 2023-10-26 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,500 | 7.97 | 19.9K | 5,304,177 | — | ↗ |
| 2023-10-25 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,500 | 7.91 | 19.8K | 5,301,677 | — | ↗ |
| 2023-10-10 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,000 | 9.07 | 9.1K | 5,299,177 | — | ↗ |
| 2023-10-04 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,000 | 8.63 | 17.3K | 5,298,177 | — | ↗ |
| 2023-09-26 | Thompson Jaye | Officer | P-Purchase | A | Common Stock | 600 | 8.71 | 5.2K | 259,848 | — | ↗ |
| 2023-09-19 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 4,000 | 8.95 | 35.8K | 5,296,177 | — | ↗ |
| 2023-09-11 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,000 | 9.48 | 9.5K | 5,292,177 | — | ↗ |
| 2023-08-22 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,000 | 9.97 | 10.0K | 5,291,177 | — | ↗ |
| 2023-08-04 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,000 | 10.55 | 21.1K | 5,290,177 | — | ↗ |
| 2023-07-21 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,000 | 9.20 | 9.2K | 5,288,177 | — | ↗ |
| 2023-07-13 | Thompson Jaye | Officer | P-Purchase | A | Common Stock | 250 | 9.49 | 2.4K | 259,248 | — | ↗ |
| 2023-05-17 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,000 | 11.69 | 11.7K | 5,287,177 | — | ↗ |
| 2023-04-28 | Thompson Jaye | Officer | P-Purchase | A | Common Stock | 250 | 11.22 | 2.8K | 258,998 | — | ↗ |
| 2023-04-19 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 7,000 | 11.10 | 77.7K | 5,286,177 | — | ↗ |
| 2023-04-18 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,000 | 11.12 | 22.2K | 5,279,177 | — | ↗ |
| 2023-04-11 | Thompson Jaye | Officer | P-Purchase | A | Common Stock | 1,000 | 11.87 | 11.9K | 258,745 | — | ↗ |
| 2023-04-11 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 5,000 | 12.42 | 62.1K | 5,271,177 | — | ↗ |
| 2023-03-15 | Thompson Jaye | Officer | P-Purchase | A | Common Stock | 250 | 12.71 | 3.2K | 257,745 | — | ↗ |
| 2023-03-10 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,000 | 12.12 | 12.1K | 2,737,486 | — | ↗ |
| 2023-02-24 | Thompson Jaye | Officer | P-Purchase | A | Common Stock | 250 | 15.40 | 3.8K | 257,495 | — | ↗ |
| 2023-02-17 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 600 | 16.53 | 9.9K | 2,736,486 | — | ↗ |
| 2023-02-10 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,000 | 18.68 | 18.7K | 2,735,886 | — | ↗ |
| 2023-02-03 | Thompson Jaye | Officer | P-Purchase | A | Common Stock | 250 | 20.84 | 5.2K | 257,245 | — | ↗ |
| 2023-01-27 | Thompson Jaye | Officer | P-Purchase | A | Common Stock | 250 | 19.20 | 4.8K | 256,995 | — | ↗ |
| 2023-01-27 | Patel Snehal | Officer | P-Purchase | A | Common Stock | 2,000 | 19.35 | 38.7K | 2,734,886 | — | ↗ |
| 2023-01-20 | Patel Snehal | Officer | P-Purchase | A | Common Stock | 1,500 | 17.37 | 26.1K | 2,732,886 | — | ↗ |
| 2023-01-13 | Thompson Jaye | Officer | P-Purchase | A | Common Stock | 250 | 16.50 | 4.1K | 256,745 | — | ↗ |
| 2023-01-06 | Patel Snehal | Officer | P-Purchase | A | Common Stock | 1,500 | 15.18 | 22.8K | 2,731,386 | — | ↗ |
| 2022-12-29 | Patel Snehal | Officer | P-Purchase | A | Common Stock | 4,000 | 15.19 | 60.8K | 2,729,886 | — | ↗ |
| 2022-12-16 | Thompson Jaye | Officer | P-Purchase | A | Common Stock | 250 | 12.94 | 3.2K | 256,495 | — | ↗ |
| 2022-12-16 | Patel Snehal | Officer | P-Purchase | A | Common Stock | 1,000 | 13.01 | 13.0K | 2,725,886 | — | ↗ |
| 2022-12-09 | Patel Snehal | Officer | P-Purchase | A | Common Stock | 2,000 | 13.11 | 26.2K | 2,724,886 | — | ↗ |
| 2022-12-02 | Thompson Jaye | Officer | P-Purchase | A | Common Stock | 250 | 13.98 | 3.5K | 256,245 | — | ↗ |
| 2022-12-02 | Patel Snehal | Officer | P-Purchase | A | Common Stock | 1,000 | 13.84 | 13.8K | 2,722,886 | — | ↗ |
| 2022-11-02 | Patel Snehal | Officer | P-Purchase | A | Common Stock | 2,000 | 8.79 | 17.6K | 2,721,886 | — | ↗ |
| 2022-10-14 | Patel Snehal | Officer | P-Purchase | A | Common Stock | 3,000 | 9.75 | 29.3K | 2,719,886 | — | ↗ |
| 2022-10-07 | Patel Snehal | Officer | P-Purchase | A | Common Stock | 2,000 | 9.72 | 19.4K | 2,716,886 | — | ↗ |
| 2022-09-30 | Patel Snehal | Officer | P-Purchase | A | Common Stock | 1,000 | 9.46 | 9.5K | 2,714,886 | — | ↗ |
| 2022-09-29 | Patel Snehal | Officer | P-Purchase | A | Common Stock | 1,000 | 9.23 | 9.2K | 2,713,886 | — | ↗ |
| 2022-06-24 | Patel Snehal | Officer | P-Purchase | A | Common Stock | 22,535 | 9.13 | 205.7K | 2,706,421 | — | ↗ |
| 2022-06-22 | Thompson Jaye | Officer | A-Award | A | Stock Options | 149,818 | 0.00 | — | 149,818 | — | ↗ |
| 2022-06-22 | Rothe Eric | Director | A-Award | A | Stock Options | 41,349 | 0.00 | — | 41,349 | — | ↗ |
| 2022-06-22 | Patel Snehal | Officer | A-Award | A | Stock Options | 25,008 | 0.00 | — | 1,073,731 | — | ↗ |
| 2022-06-22 | McWilliams David | Director | A-Award | A | Stock Options | 61,984 | 0.00 | — | 61,984 | — | ↗ |
| 2022-06-22 | Hallock Kenneth | Director | A-Award | A | Stock Options | 41,349 | 7.63 | 315.5K | 41,349 | — | ↗ |
| 2022-06-22 | Daugherty Frank Joseph | Director / Officer | A-Award | A | Stock Options | 104,890 | 7.63 | 800.3K | 104,890 | — | ↗ |
| 2022-06-16 | Patel Snehal | Officer | P-Purchase | A | Common Stock | 8,000 | 7.13 | 57.0K | 2,683,886 | — | ↗ |
| 2022-06-14 | Patel Snehal | Officer | P-Purchase | A | Common Stock | 12,000 | 7.91 | 94.9K | 2,675,886 | — | ↗ |
| 2022-06-10 | Patel Snehal | Officer | P-Purchase | A | Common Stock | 12,000 | 8.33 | 100.0K | 2,663,886 | — | ↗ |
| 2022-06-09 | Patel Snehal | Officer | P-Purchase | A | Common Stock | 4,500 | 10.90 | 49.1K | 1,243,453 | — | ↗ |
| 2022-06-07 | Patel Snehal | Officer | P-Purchase | A | Common Stock | 6,000 | 8.55 | 51.3K | 1,238,953 | — | ↗ |
| 2022-06-03 | Patel Snehal | Officer | P-Purchase | A | Common Stock | 9,250 | 8.35 | 77.2K | 1,232,953 | — | ↗ |
| 2022-06-02 | Patel Snehal | Officer | P-Purchase | A | Common Stock | 6,774 | 7.38 | 50.0K | 1,223,703 | — | ↗ |
| 2022-04-25 | Daugherty Frank Joseph | Officer | P-Purchase | A | Common Stock | 1,000 | 16.25 | 16.3K | 90,121 | — | ↗ |
| 2022-04-21 | Patel Snehal | Officer | P-Purchase | A | Common Stock | 6,000 | 16.09 | 96.5K | 1,216,929 | — | ↗ |
| 2022-04-19 | Thompson Jaye | Officer | P-Purchase | A | Common Stock | 500 | 16.74 | 8.4K | 255,995 | — | ↗ |
| 2022-04-19 | Patel Snehal | Officer | P-Purchase | A | Common Stock | 6,000 | 16.74 | 100.4K | 1,210,929 | — | ↗ |
| 2022-02-11 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 5,500 | 19.80 | 108.9K | 1,204,929 | — | ↗ |
| 2022-02-04 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 5,000 | 19.59 | 98.0K | 1,199,429 | — | ↗ |
| 2022-01-31 | Thompson Jaye | Officer | P-Purchase | A | Common Stock | 500 | 18.47 | 9.2K | 255,495 | — | ↗ |
| 2022-01-21 | Thompson Jaye | Officer | P-Purchase | A | Common Stock | 500 | 16.33 | 8.2K | 254,995 | — | ↗ |
| 2022-01-21 | Hallock Kenneth | Director | P-Purchase | A | Common Stock | 300 | 16.32 | 4.9K | 397,304 | — | ↗ |
| 2022-01-18 | Thompson Jaye | Officer | P-Purchase | A | Common Stock | 500 | 18.87 | 9.4K | 254,495 | — | ↗ |
| 2022-01-13 | Thompson Jaye | Officer | P-Purchase | A | Common Stock | 1,000 | 19.99 | 20.0K | 253,995 | — | ↗ |
| 2022-01-13 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,000 | 19.99 | 20.0K | 1,194,429 | — | ↗ |
| 2022-01-13 | Daugherty Frank Joseph | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 19.99 | 20.0K | 89,121 | — | ↗ |
| 2022-01-03 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,050 | 23.82 | 48.8K | 1,193,429 | — | ↗ |
| 2021-12-20 | Thompson Jaye | Officer | — | D | Common Stock | 0 | 0.00 | — | 252,995 | — | ↗ |
| 2021-12-14 | Patel Snehal | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,840 | 27.17 | 50.0K | 1,191,379 | — | ↗ |
| 2021-12-14 | McWilliams David | Director | P-Purchase | A | Common Stock | 200 | 27.56 | 5.5K | 620,301 | — | ↗ |
| 2021-12-14 | Daugherty Frank Joseph | Director / Officer | P-Purchase | A | Common Stock | 1,111 | 26.99 | 30.0K | 88,121 | — | ↗ |
| 2021-04-13 | Patel Snehal | Director / Officer | P-Purchase | A | Common Stock | 2,700 | 36.98 | 99.9K | 1,189,539 | — | ↗ |
| 2020-11-24 | Hallock Kenneth | Director | P-Purchase | A | Common Stock | 1,000 | 5.39 | 5.4K | 397,004 | — | ↗ |
| 2020-11-23 | Daugherty Frank Joseph | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 5.10 | 5.1K | 87,010 | — | ↗ |
| 2020-11-20 | Rothe Eric | Director | P-Purchase | A | Common Stock | 2,000 | 5.40 | 10.8K | 313,226 | — | ↗ |
| 2020-11-20 | McWilliams David | Director | P-Purchase | A | Common Stock | 1,500 | 5.40 | 8.1K | 620,101 | — | ↗ |
| 2020-11-20 | Hallock Kenneth | Director | P-Purchase | A | Common Stock | 1,000 | 5.37 | 5.4K | 396,004 | — | ↗ |
| 2020-11-19 | Patel Snehal | Director / Officer | P-Purchase | A | Common Stock | 2,000 | 5.40 | 10.8K | 1,186,839 | — | ↗ |
| 2020-11-10 | Patel Pankaj Amrit | 10% Owner | J-Other | D | Common Stock | 187,266 | 0.00 | — | 0 | — | ↗ |
| 2020-09-29 | Patel Snehal | Director / Officer | M-Exempt | D | Series D Preferred Stock | 7,292 | 0.00 | — | 0 | — | ↗ |
| 2020-09-29 | Patel Kinnary | 10% Owner | M-Exempt | A | Common Stock | 76,780 | 0.00 | — | 76,780 | — | ↗ |
| 2020-09-29 | McWilliams David | Director | M-Exempt | A | Common Stock | 7,609 | 0.00 | — | 618,601 | — | ↗ |
| 2020-09-29 | Hallock Kenneth | Director | M-Exempt | A | Common Stock | 79,121 | 0.00 | — | 386,671 | — | ↗ |
| 2020-09-29 | Daugherty Frank Joseph | Director / Officer | P-Purchase | A | Common Stock | 1,739 | 5.75 | 10.0K | 86,010 | — | ↗ |
| 2020-09-24 | Thompson Jaye | Officer | — | D | Common stock | 0 | 0.00 | — | 140,450 | — | ↗ |
| 2020-09-24 | Rothe Eric | Director | — | D | Common stock | 0 | 0.00 | — | 311,226 | — | ↗ |
| 2020-09-24 | Patel Snehal | Director / Officer | — | I | Series A Preferred Stock | 1,144,529 | 0.00 | — | 0 | — | ↗ |
| 2020-09-24 | Patel Panjaj Amrit | 10% Owner | — | I | Common stock | 0 | 0.00 | — | 187,266 | — | ↗ |
| 2020-09-24 | Patel Kinnary | 10% Owner | — | I | Series B Preferred Stock | 76,780 | 0.00 | — | 0 | — | ↗ |
| 2020-09-24 | McWilliams David | Director | — | D | Common stock | 0 | 0.00 | — | 444,371 | — | ↗ |
| 2020-09-24 | Hallock Kenneth | Director | — | I | Common stock | 0 | 0.00 | — | 182,586 | — | ↗ |
| 2020-09-24 | Daugherty Frank Joseph | Director / Officer | — | D | Common stock | 0 | 0.00 | — | 84,271 | — | ↗ |
Executive team
Top executives
Shares Outstanding
13.85M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Snehal Patel, Chief Executive Officer | 612.6K | 306.3K | 5.32M | — | — | — | 6.24M | 85.28% | ↗ |
| 2 | 2023 | Snehal Patel, Chief Executive Officer | 556.9K | 528.4K | 1.66M | — | — | — | 2.75M | 60.53% | ↗ |
| 3 | 2022 | Snehal Patel, Chief Executive Officer | 506.3K | 503.1K | 1.24M | — | — | — | 2.25M | 55.18% | ↗ |
| 4 | 2021 | Snehal Patel, Chief Executive Officer | 450.0K | 475.0K | 491.6K | — | — | — | 1.42M | 34.70% | ↗ |
| 5 | 2021 | Snehal Patel, CEO | 450.0K | 475.0K | 491.6K | — | — | — | 1.42M | 34.70% | ↗ |
| 6 | 2020 | Snehal Patel, CEO | 115.0K | 392.5K | 491.6K | — | — | — | 999.1K | 49.20% | ↗ |
| 7 | 2019 | Snehal Patel, CEO | — | — | 122.8K | — | — | 16.4K | 139.2K | 88.20% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Snehal S. Patel | Chief Executive Officer, Chief Financial Officer & Director | 918.8K | male |
| Eric Rothe | Founder & Independent Director | 65.6K | male |
| Christine T. Fischette | Vice President of Business Development | — | — |
| Frank Joseph Daugherty | Chief Medical Officer & Director | — | — |
| Jaye L. Thompson | Vice President Clinical & Regulatory Affairs | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GLSI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
